ICF International (NASDAQ:ICFI), a leading provider of professional services and technology-based solutions to government and commercial clients, has named Audie Atienza, Ph.D. to the position of senior fellow for ICF’s biomedical informatics team.
Atienza has more than 15 years of experience in leading behavioral science and health information technology programs for the U.S. Department of Health and Human Services (HHS), and supporting multiple data science, big data and mobile initiatives. At ICF, he will be responsible for growing the company’s clinical research and biomedical informatics areas, with a deep focus in applying data analytics capabilities to the healthcare arena.
"Dr. Atienza has a unique base of experience in shaping policy and addressing large data challenges for the healthcare and biomedical scientific community," said Matthew Perry, senior vice president for ICF. "He will be a great asset to ICF’s continued expansion as we further our support to the country’s health initiatives such as the President’s Precision Medicine Initiative and the cancer ‘moonshot’ prescribed in President Obama’s recent State of the Union address."
Prior to joining ICF, Atienza spent over a decade delivering and overseeing research on cancer prevention, health technology innovation and other topics for the U.S. National Cancer Institute. Most recently, Atienza held the positions of senior advisor to the Associate Director for Data Science at the National Institutes of Health (NIH), and behavioral scientist in the Science of Research and Technology Branch at the National Cancer Institute. Atienza previously served as senior advisor to the chief technology officer at the HHS, Office of the Secretary, where he led health technology initiatives in collaboration with the White House, the Office of the U.S. Surgeon General, and the Office of the National Coordinator for Health Information Technology. He has also served special assignments to the HHS chief information officer and to the NIH’s associate director for data science.
Atienza holds a bachelor’s degree in psychology from the University of California at San Diego, a master’s degree and a doctorate degree in clinical psychology, with an emphasis in health psychology and behavioral medicine, from Kent State University in Ohio. He completed a clinical internship as a psychologist at the U.S. Department of Veterans Affairs Palo Alto Health Care System, and was selected as a post-doctoral research fellow at the Stanford University School of Medicine, Stanford Prevention Research Center in cardiovascular disease epidemiology and prevention.
For More Information
ICF (NASDAQ:ICFI) is a global consulting and technology services provider with more than 5,000 professionals focused on making big things possible for our clients. We are business analysts, policy specialists, technologists, researchers, digital strategists, social scientists and creatives. Since 1969, government and commercial clients have worked with ICF to overcome their toughest challenges on issues that matter profoundly to their success. Come engage with us at icf.com.
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; and our ability to acquire and successfully integrate businesses. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements are included in the "Risk Factors" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.